Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 453

1.

Rapid, Low Temperature Formation of Imine-linked COFs Catalyzed by Metal Triflates.

Matsumoto M, Dasari RR, Ji W, Feriante CH, Parker TC, Marder SR, Dichtel WR.

J Am Chem Soc. 2017 Mar 27. doi: 10.1021/jacs.7b01240. [Epub ahead of print]

PMID:
28345908
2.

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.

Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF.

Am J Psychiatry. 2017 Mar 21:appiajp201716091037. doi: 10.1176/appi.ajp.2017.16091037. [Epub ahead of print]

PMID:
28320223
3.

Older Brains are Different: Brain-Behavior Studies and Their Clinical Utility.

Sultzer DL, Marder SR.

Am J Geriatr Psychiatry. 2017 Jan;25(1):11-12. doi: 10.1016/j.jagp.2016.10.002. Epub 2016 Oct 6. No abstract available.

PMID:
28231870
4.

Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ).

Buck B, Iwanski C, Healey KM, Green MF, Horan WP, Kern RS, Lee J, Marder SR, Reise SP, Penn DL.

J Psychiatr Res. 2017 Jan 9;89:48-54. doi: 10.1016/j.jpsychires.2017.01.004. [Epub ahead of print]

PMID:
28160626
5.

The current conceptualization of negative symptoms in schizophrenia.

Marder SR, Galderisi S.

World Psychiatry. 2017 Feb;16(1):14-24. doi: 10.1002/wps.20385.

6.

Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.

Bugarski-Kirola D, Blaettler T, Arango C, Fleischhacker WW, Garibaldi G, Wang A, Dixon M, Bressan RA, Nasrallah H, Lawrie S, Napieralski J, Ochi-Lohmann T, Reid C, Marder SR.

Biol Psychiatry. 2016 Dec 15. pii: S0006-3223(16)33109-2. doi: 10.1016/j.biopsych.2016.11.014. [Epub ahead of print]

PMID:
28117049
7.

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

Charney AW, Ruderfer DM, Stahl EA, Moran JL, Chambert K, Belliveau RA, Forty L, Gordon-Smith K, Di Florio A, Lee PH, Bromet EJ, Buckley PF, Escamilla MA, Fanous AH, Fochtmann LJ, Lehrer DS, Malaspina D, Marder SR, Morley CP, Nicolini H, Perkins DO, Rakofsky JJ, Rapaport MH, Medeiros H, Sobell JL, Green EK, Backlund L, Bergen SE, Juréus A, Schalling M, Lichtenstein P, Roussos P, Knowles JA, Jones I, Jones LA, Hultman CM, Perlis RH, Purcell SM, McCarroll SA, Pato CN, Pato MT, Craddock N, Landén M, Smoller JW, Sklar P.

Transl Psychiatry. 2017 Jan 10;7(1):e993. doi: 10.1038/tp.2016.242.

PMID:
28072414
8.

Absorption Tails of Donor:C60 Blends Provide Insight into Thermally Activated Charge-Transfer Processes and Polaron Relaxation.

Vandewal K, Benduhn J, Schellhammer KS, Vangerven T, Rückert JE, Piersimoni F, Scholz R, Zeika O, Fan Y, Barlow S, Neher D, Marder SR, Manca J, Spoltore D, Cuniberti G, Ortmann F.

J Am Chem Soc. 2017 Feb 1;139(4):1699-1704. doi: 10.1021/jacs.6b12857. Epub 2017 Jan 24.

PMID:
28068763
9.

Understanding How Charged Nanoparticles Electrostatically Assemble and Distribute in 1-D.

Carroll KM, Wolf H, Knoll A, Curtis JE, Zhang Y, Marder SR, Riedo E, Duerig U.

Langmuir. 2016 Dec 27;32(51):13600-13610. doi: 10.1021/acs.langmuir.6b03471. Epub 2016 Dec 15.

PMID:
27977208
10.

Influence of Molecular Aggregation on Electron Transfer at the Perylene Diimide/Indium-Tin Oxide Interface.

Zheng Y, Jradi FM, Parker TC, Barlow S, Marder SR, Saavedra SS.

ACS Appl Mater Interfaces. 2016 Dec 14;8(49):34089-34097. Epub 2016 Nov 30.

PMID:
27960436
11.

Solution-based electrical doping of semiconducting polymer films over a limited depth.

Kolesov VA, Fuentes-Hernandez C, Chou WF, Aizawa N, Larrain FA, Wang M, Perrotta A, Choi S, Graham S, Bazan GC, Nguyen TQ, Marder SR, Kippelen B.

Nat Mater. 2016 Dec 5. doi: 10.1038/nmat4818. [Epub ahead of print]

PMID:
27918568
12.

Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies.

Marder SR, Hakala MJ, Josiassen MK, Zhang P, Ouyang J, Weiller E, Weiss C, Hobart M.

Acta Neuropsychiatr. 2016 Nov 16:1-13. [Epub ahead of print]

PMID:
27846922
13.

How Occupationally High-Achieving Individuals With a Diagnosis of Schizophrenia Manage Their Symptoms.

Cohen AN, Hamilton AB, Saks ER, Glover DL, Glynn SM, Brekke JS, Marder SR.

Psychiatr Serv. 2016 Nov 15:appips201600031. [Epub ahead of print]

PMID:
27842472
14.

An RCT Evaluating the Effects of Skills Training and Medication Type on Work Outcomes Among Patients With Schizophrenia.

Glynn SM, Marder SR, Noordsy DL, O'Keefe C, Becker DR, Drake RE, Sugar CA.

Psychiatr Serv. 2017 Mar 1;68(3):271-277. doi: 10.1176/appi.ps.201500171. Epub 2016 Nov 1.

PMID:
27799019
15.

Repurposing Drugs for Cognition in Schizophrenia.

Yang YS, Marder SR, Green MF.

Clin Pharmacol Ther. 2017 Feb;101(2):191-193. doi: 10.1002/cpt.529. Epub 2016 Nov 24.

PMID:
27706797
16.

A Study on Reducing Contact Resistance in Solution-Processed Organic Field-Effect Transistors.

Choi S, Fuentes-Hernandez C, Wang CY, Khan TM, Larrain FA, Zhang Y, Barlow S, Marder SR, Kippelen B.

ACS Appl Mater Interfaces. 2016 Sep 21;8(37):24744-52. doi: 10.1021/acsami.6b07029. Epub 2016 Sep 12.

PMID:
27579570
17.

Facile Incorporation of Pd(PPh3)2Hal Substituents into Polymethines, Merocyanines, and Perylene Diimides as a Means of Suppressing Intermolecular Interactions.

Davydenko I, Barlow S, Sharma R, Benis S, Simon J, Allen TG, Cooper MW, Khrustalev V, Jucov EV, Castañeda R, Ordonez C, Li Z, Chi SH, Jang SH, Parker TC, Timofeeva TV, Perry JW, Jen AK, Hagan DJ, Van Stryland EW, Marder SR.

J Am Chem Soc. 2016 Aug 17;138(32):10112-5. doi: 10.1021/jacs.6b06361. Epub 2016 Aug 5.

PMID:
27494823
18.

Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial.

Barch DM, Marder SR, Harms MP, Jarskog LF, Buchanan RW, Cronenwett W, Chen LS, Weiss M, Maguire RP, Pezous N, Feuerbach D, Lopez-Lopez C, Johns DR, Behrje RB, Gomez-Mancilla B.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Nov 3;71:66-75. doi: 10.1016/j.pnpbp.2016.06.013. Epub 2016 Jun 28.

PMID:
27371157
19.

Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research.

Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AF, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA Jr, Carter CS, Cook EH Jr, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA Jr, Zubieta JK.

Biol Psychiatry. 2016 Jul 15;80(2):84-6. doi: 10.1016/j.biopsych.2016.05.004. No abstract available.

PMID:
27346079
20.

Controlled n-Type Doping of Carbon Nanotube Transistors by an Organorhodium Dimer.

Geier ML, Moudgil K, Barlow S, Marder SR, Hersam MC.

Nano Lett. 2016 Jul 13;16(7):4329-34. doi: 10.1021/acs.nanolett.6b01393. Epub 2016 Jun 6.

PMID:
27253896

Supplemental Content

Loading ...
Support Center